|
POLICY & REGULATION
ENFORCEMENT
LITIGATION
ImmunityBio Stockholder Targets Soon-Shiong In Chancery
By Jarek Rutz
The Delaware Chancery Court on Tuesday heard arguments over whether biotech billionaire Patrick Soon-Shiong and ImmunityBio Inc.'s board breached their fiduciary duties by approving insider financing that allegedly allowed him to secure equity at deeply discounted prices as the company neared regulatory approval for its lead cancer drug.
4 documents attached |
Read full article »
| Save to favorites »
PEOPLE
EXPERT ANALYSIS
LEGAL INDUSTRY
|